Oritavancin for the treatment of complicated gram-positive infection in persons who inject drugs

Overview of attention for article published in BMC Pharmacology and Toxicology, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 489)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 35 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 39 X posts from 35 X users, with an upper bound of 357,125 followers.

RT @UMN_ID: Here are some excellent resources for this clinical scenario. First, a paper by @ailley_. What is your experience with oritavan…

01 Nov 2022

Reply Repost Favourite

Here are some excellent resources for this clinical scenario. First, a paper by @ailley_. What is your experience with oritavancin in your center? 2/ https://t.co/b4Y5KukpRf

01 Nov 2022

Reply Repost Favourite

RT @ailley_: It took 3 years, but my FIRST paper was just published! Thank you to everyone, especially my coauthor Heather, for their suppo…

18 Feb 2022

Reply Repost Favourite

RT @ailley_: @IdVilchez @wfwrighID @DrToddLee @SAIRABT @Cortes_Penfield @transplantID @JGPharmD @ConanMacDougall @njrhodes_rx @Josh_S_Davis…

02 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 35 additional X posts.